Adverse events
nausea, insomnia, disability
ADVERSE EVENTS, ADVERSE EVENT
The incidence and severity of adverse events were tracked during the testing sessions and throughout the remainder of the testing day. Specifically, during the testing sessions, the participants were encouraged to provide details about any adverse events (e.g., nausea). After the testing was completed, the participants were also required to record any additional adverse events (e.g., insomnia, irregular heartbeat, etc.). If an adverse event occurred, the participants were required to note its description, the likelihood of its association with the intervention (not related, unlikely, possibly, probably, definite), severity (life-threatening, required hospitalization, resulted in persistent disability, or non-serious), and its intensity (mild, moderate, severe, life-threatening) [